Colinz Laboratories Share Price

Colinz Laboratories

CMP as on30-Jul-21 15:15

₹ 24.05
0.85 3.66%

Open

₹ 23.00

Turnover (lac)

₹ 1

Prev. Close

₹ 23.20

Day's Vol (shares)

₹ 1,604

Day's Range

₹ 22.05
₹ 24.10

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 14-Jul-2021 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2021 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Friday, 14th August, 2020 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra - 400078 inter-alia.
Board Meeting - 07-May-2021 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Thursday, 27th May, 2021 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund ink Road, Mumbai, Maharashtra, 400078, at 3.30 p.m. inter-alia to consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended 31st March, 2021. In terms of provisions of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), this is to inform you that the Board of Directors, at its Meeting held today, i.e., 27th May, 2021, has inter alia transacted the following business items : In accordance with Regulation 33 of the Listing Regulations: a. The Board has discussed and approved Annual Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (IND- AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2021 together with the Audit Reports with unmodified opinion(s) in respect of Standalone Financial Results, as submitted by the Auditors of the Company. b. Declaration duly certified by the Chief Financial Officer of the Company to the effect that Auditors have submitted their Report with unmodified opinion. (As per BSE Announcement Dated on 27/05/2021)
Board Meeting - 12-Jan-2021 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2021 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on 30th January, 2021 at 03.30 P.M. at the registered office of the Company at A-101, Pratik Industrial Estate, next to Fortis Hospital, Mulund Goregaon Link Road, Mumbai-400078, Maharashtra inter-alia to consider, approve and take on record the Un-Audited Financial Results of the Company for the Quarter and Nine Months ended 31st December, 2020 Please find enclosed herewith Newspaper Clippings of Un-Audited Financial Results for the Quarter Ended on 31St December, 2020 published in FREE PRESS JOURNAL and NAVSHAKTI on 31st January, 2021 in pursuance of Regulation 47(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which were approved in the Board meeting held on 30th January, 2021. (As per BSE Announcement Dated on 1/2/2021)
Board Meeting - 15-Oct-2020 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2020 ,inter alia, to consider and approve THIS TO INFORM YOU THAT THE PURSUANT TO SEBI REGULATION 29(2) OF (LODR), REGULATIONS, 2015. ID SCHEDULED TO BE HELD ON 31-10-2020 AT THE REGISTERED OFFICE OF THE COMPANY. AT 3.30 PM We would like to inform you that , the Board of Directors of the Company at their meeting held today i.e. 31st October, 2020 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS ) for the quarter and half year ended on 30th September, 2020
Board Meeting - 05-Aug-2020 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2020 ,inter alia, to consider and approve 1. To Approve Unaudited Financial Results for the Quarter Ended, 30th June, 2020. 2. To approve Directors Report for the year ended as on 31st March, 2020. 3. To approve Management discussion, Corporate Governance report, CEOs certification & other documents, if any. 4. To take note of Secretarial Audit Report issued by M/s. Sanjay Dholakia & Associates, Practicing Company Secretaries for the financial year ended 31st March, 2020. 5. To Decide the Date, time, venue and mode of Annual General Meeting and Approve Notice of AGM. 6. To Fix dates of Book Closure & Record Date. 7. To consider & approve Appointment of M/s. Sanjay Dholakia & Associates, Practicing Company Secretaries as the Secretarial Auditor for the financial year ended 31st March, 2021. 8. To grant authority to file relevant Forms with MCA w.r.t forthcoming AGM 9. To take note of the entries in the Statutory Register. 10. To consider any other business with the permission of Chair. The Board approved the agenda as per the intimation given to BSE on 14-08-2020 as per the outcome attached (As Per BSE Announcement Dated on 14/08/2020)
Open ZERO Brokerage Demat Account